Sudan Ebolavirus (SUDV): Symptoms, Transmission and Treatment
Sudan ebolavirus (SUDV) is a highly dangerous pathogen of the family Filoviridae that causes severe viral hemorrhagic fever with a high case fatality rate.
Things worth knowing about "Sudan ebolavirus"
Sudan ebolavirus (SUDV) is a highly dangerous pathogen of the family Filoviridae that causes severe viral hemorrhagic fever with a high case fatality rate.
What is Sudan Ebolavirus?
Sudan ebolavirus (SUDV) is one of several species within the genus Orthoebolavirus, belonging to the family Filoviridae. It is one of the causative agents of Ebola virus disease (EVD), a life-threatening viral hemorrhagic fever. The virus was first identified in 1976 during an outbreak in Sudan (now South Sudan), occurring simultaneously with the first known Zaire ebolavirus outbreak in what was then Zaire. Since then, Sudan ebolavirus has been responsible for several additional outbreaks in East Africa, including a significant outbreak in Uganda in 2022.
Causes and Transmission
Sudan ebolavirus is transmitted through direct contact with the body fluids of infected individuals or animals, including blood, saliva, sweat, urine, vomit, and other secretions. Airborne transmission has not been documented. Fruit bats are considered the most likely natural reservoir, although this has not been conclusively confirmed for SUDV. Zoonotic transmission from animals to humans is possible. Within healthcare settings and households, the virus can spread rapidly if infection control measures are inadequate.
Symptoms
The incubation period typically ranges from 2 to 21 days. The illness usually begins abruptly with:
- High fever
- Severe headache
- Muscle and joint pain
- General weakness and fatigue
- Nausea, vomiting, and diarrhea
- Abdominal pain
As the disease progresses, more severe symptoms may develop, including:
- Hemorrhagic manifestations (internal and external bleeding)
- Liver and kidney failure
- Multi-organ failure
- Shock
The case fatality rate for Sudan ebolavirus ranges between 41 and 65 percent depending on the outbreak, making it slightly lower than Zaire ebolavirus but still extremely high.
Diagnosis
Diagnosing a Sudan ebolavirus infection requires specialized laboratory testing under the highest biosafety conditions (BSL-4). The following methods are used:
- RT-PCR (Reverse Transcription Polymerase Chain Reaction): Detection of viral RNA in blood; considered the gold standard
- ELISA (Enzyme-Linked Immunosorbent Assay): Detection of viral antigens or specific antibodies
- Electron microscopy: Direct visualization of the virus in samples
- Virus isolation: Culturing the virus under BSL-4 conditions
Clinical diagnosis alone is insufficient due to the overlap of symptoms with other diseases such as malaria and typhoid fever.
Treatment
As of today, there is no specifically approved antiviral treatment for Sudan ebolavirus. Management is primarily supportive:
- Intravenous fluid replacement to compensate for fluid losses
- Correction of electrolyte imbalances
- Supplemental oxygen when needed
- Medications to manage blood pressure and pain
- Treatment of secondary infections
Unlike Zaire ebolavirus, the monoclonal antibodies approved for ZEBOV (e.g., Atoltivimab/Maftivimab/Odesivimab or Ansuvimab) are not effective against SUDV, as these antibodies target the Zaire-specific glycoprotein. Vaccine candidates and antiviral therapeutics specifically targeting Sudan ebolavirus are currently under development and being tested in clinical trials.
Prevention and Infection Control
Since no approved SUDV-specific vaccine is currently available (as of 2024, candidates remain in clinical trials), prevention relies on:
- Personal protective equipment (PPE) for healthcare workers (gloves, protective clothing, masks, face shields)
- Isolation of infected individuals
- Safe burial practices for deceased individuals (avoiding direct contact with remains)
- Community education about transmission routes and preventive behaviors Contact tracing and quarantine of exposed individuals
References
- World Health Organization (WHO): Ebola virus disease - Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease (2023)
- Feldmann H, Geisbert TW: Ebola haemorrhagic fever. Lancet. 2011;377(9768):849-862. doi:10.1016/S0140-6736(10)60667-8
- Centers for Disease Control and Prevention (CDC): Sudan Ebolavirus. https://www.cdc.gov/vhf/ebola/resources/virus-ecology.html (2023)
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryUrethral irrigation
Hemiparesis
Osteolysis
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Sudan ebolavirus